Plus Therapeutics Approves FY2025 Cash Bonuses: CEO Hedrick Gets $305,663, CFO Sims Gets $149,175

PLUS THERAPEUTICS, INC.

On Feb 9, 2026, Compensation Committee approved discretionary cash bonuses for Named Executive Officers for FY2025.
CEO Marc H. Hedrick received a $305,663 cash bonus; total 2025 compensation was $5,566,732.
CFO Andrew Sims received a $149,175 cash bonus; total 2025 compensation was $1,631,279.
Former CMO Norman LaFrance, who stepped down in June 2024, received $0 compensation in FY2025.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-051379
form_type: 8-K
ticker: PSTV
cik: 0001095981
company_name: PLUS THERAPEUTICS, INC.
filed_at: 2026-02-13T23:59:59+00:00
discovered_at: 2026-05-14T18:02:34.532774+00:00
generated_at: 2026-05-16T02:42:54.335352+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-051379
json_url: https://secwatch.observer/filing/0001193125-26-051379.json
markdown_url: https://secwatch.observer/filing/0001193125-26-051379.md
text_url: https://secwatch.observer/filing/0001193125-26-051379.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/0001193125-26-051379-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/pstv-20260209.htm
generated_by_model: deepseek-v4-flash:cloud
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-051379

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.